Inflammatory Neuropathy Consortium Base
Recruiting
- Conditions
- chronic inflammatory demyelinating polyneuropathieCIDP10029317
- Registration Number
- NL-OMON49801
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
clinical suspicion of the diagnosis CIDP
Exclusion Criteria
The presence of any condition, that at the discretion of the study investigator
or study participant, impairs the participants ability to provide accurate
study information in a timely and reliable manner
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Prediction model to predict treatment response</p><br>
- Secondary Outcome Measures
Name Time Method <p>1) to discover clinical, electrophysiological and biological biomarkers for<br /><br>diagnosis, disease activity and prognosis, 2) to describe variation in clinical<br /><br>and electrophysiological characteristics of CIDP to define the spectrum and<br /><br>boundaries of CIDP, 3) to describe short and long-term outcomes at impairment,<br /><br>disability and quality of life levels of (subgroups of) CIDP patients, 4) to<br /><br>discover clinical, electrophysiological and biological determinants of<br /><br>treatment response and long-term outcomes, 5) to describe physician and patient<br /><br>perspectives on and satisfaction with different treatments that may be used for<br /><br>CIDP, including plasma-exchange and subcutaneous immunoglobulin and 6) to<br /><br>deepen knowledge on CIDP pathophysiology, including investigating immunological<br /><br>pathways underlying CIDP.</p><br>